January 30, 2015 5:27 PM ET


Company Overview of Vantia Ltd

Company Overview

Vantia Ltd., a pharmaceutical company, develops molecule drugs targeting large areas of unmet medical needs. Its pipeline of products include Fedovapagon (VA106483), a novel small molecule drug candidate that is used for the treatment of nocturia, a common condition that causes sufferers to wake frequently during the night in order to urinate; and VA111913, a molecule drug that is used for the treatment of dysmenorrhoea. Vantia Ltd. was incorporated in 2007 and is based in Southampton, United Kingdom.

Phi House

Enterprise Road

Southampton Science Park

Southampton,  SO16 7NS

United Kingdom

Founded in 2007


44 11 7916 7693


44 23 8001 5945

Key Executives for Vantia Ltd

Chief Executive Officer and Director
Age: 39
Founder and Chief Operating Officer
Chief Financial Officer
Head of Regulatory Affairs
Advisor to the Board
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Galpharm International Ltd. Europe
OSI Pharmaceuticals (UK) Limited Europe
Enigma Therapeutics Ltd Europe
SHS International Ltd. Europe
Synpac Pharmaceuticals Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vantia Ltd, please visit www.vantia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.